Past Event
Building a High Quality US-Mexico Pharmaceutical Supply Chain
Submit a question
Objectives
- Describe the current framework that could allow interactions between US and Mexican players to partner on pharmaceutical nearshoring efforts to build up a strong binational quality supply chain for APIs and medicines.
- Show commitment, policies, and initiatives of US and Mexican governments to strengthen the US-Mexico pharmaceutical quality supply chain through nearshoring initiatives.
- Show the capabilities of the innovative and generic pharmaceutical industries to provide quality APIs and medicines to strengthen the US-Mexico supply chain.
Organization
- Co-organizers: United States Pharmacopeia, The Wilson Center, Mexico Institute, and the US Embassy in Mexico.
- Sponsorship: Mexican Association of Pharmaceutical Laboratories (AMELAF)
Event Sponsors
Introductions
Andrew I. Rudman
Public Policy Fellow, Former Director, Mexico Institute
Jerry Haar
Global Fellow;
Professor of International Business and Executive Director for the Americas, College of Business, Florida International University
Professor of International Business and Executive Director for the Americas, College of Business, Florida International University
Keynote Speakers
Raquel Buenrostro
Secretary of Economy
Jose Fernandez
Under Secretary for Economic Growth, Energy, and the Environment, Department of State
Alejandro Svarch
Federal Commissioner for Protection against Sanitary Risks
Moderators
Eduardo González Pier
Global Fellow;
Global Fellow, Wilson Center; Senior Technical Director; Palladium
Global Fellow, Wilson Center; Senior Technical Director; Palladium
Anthony Lakavage
Senior Vice President, Global External Affairs, United States Pharmacopeia
Panelists
Maria Julia Marinissen
Health Attache, Embassy of the United States in Mexico
Vimala Raghavendran
Vice President, Informatics Product Development, United States Pharmacopeial
Juan de Villafranca
Executive President, Mexican Association of Pharmaceutical Laboratories (AMELAF)
Kevin Webb
Chief Operating Officer of the API Innovation Center
Cristobal Thompson
Executive Director of the Mexican Association of Pharmaceutical Research Industries
Javier Aceves
Director, PiSA Farmaceutica
Constanza Lozada
CEO, Pfizer Mexico
Leigh Verbois
Director, Office of Drug Security, Integrity and Response, Federal Drug Administration
Hosted By
Mexico Institute
The Mexico Institute seeks to improve understanding, communication, and cooperation between Mexico and the United States by promoting original research, encouraging public discussion, and proposing policy options for enhancing the bilateral relationship. A binational Advisory Board, chaired by Luis Téllez and Earl Anthony Wayne, oversees the work of the Mexico Institute. Read more
Wahba Institute for Strategic Competition
The Wahba Institute for Strategic Competition works to shape conversations and inspire meaningful action to strengthen technology, trade, infrastructure, and energy as part of American economic and global leadership that benefits the nation and the world. Read more